[
    {
        "content": "* Insulet announces pricing of convertible senior notes due 2024",
        "date": "11082017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet announces pricing of convertible senior notes due 2024 "
    },
    {
        "content": "* Insulet announces private offering of convertible senior notes",
        "date": "11062017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet announces private offering of convertible senior notes "
    },
    {
        "content": "* Q3 revenue $121.8 million versus I/B/E/S view $114.4 million",
        "date": "11022017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet Corp reports Q3 loss per share $0.04 "
    },
    {
        "content": "* Says $100 million investment in Massachusetts will provide for hundreds of local manufacturing jobs at a 350 000 square-foot facility",
        "date": "09282017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet says $100 mln investment in Massachusetts will provide for hundreds of local jobs "
    },
    {
        "content": "* Insulet Corporation appoints Michael R. Minogue and James C. Mullen to board of directors Source text for Eikon: Further company coverage:",
        "date": "08102017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet Corp appoints two board of directors "
    },
    {
        "content": "* Q2 revenue $109.8 million versus I/B/E/S view $106.2 million",
        "date": "08032017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet reports Q2 loss per share $0.13 "
    },
    {
        "content": "* TO SEPARATE FROM INSULET AND EXTEND ITS PORTFOLIO WITH AN OWN PATCH PUMP IN MID-TERM",
        "date": "07212017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Ypsomed to separate from Insulet "
    },
    {
        "content": "* Insulet to assume distribution and commercial support for its Omnipod system in Europe",
        "date": "07202017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet to assume distribution and commercial support for its Omnipod system in Europe "
    },
    {
        "content": "* Insulet presents positive omnipod\u00ae horizon\u2122 hybrid closed-loop study results in children",
        "date": "06122017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet presents positive omnipod horizon hybrid closed-loop study results in children "
    },
    {
        "content": "* Announced positive results from first feasibility study of omnipod horizon(tm) hybrid closed-loop system  Source text for Eikon:  Further company coverage:",
        "date": "02172017",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet announces positive results from feasibility study of diabetes drug "
    },
    {
        "content": "* Q3 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S",
        "date": "11032016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet Q3 loss per share $0.05 from continuing operations "
    },
    {
        "content": "* Says Jessica Hopfield  PHD  assumes role of lead independent director",
        "date": "10192016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet says Patrick Sullivan elected chairman of board "
    },
    {
        "content": "*  Enrolls first patients in clinical trial for its Omnipod artificial pancreas system  Source text for Eikon:  Further company coverage:",
        "date": "09132016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet enrolls first patients in clinical trial for its Omnipod artificial pancreas system "
    },
    {
        "content": "* Insulet announces pricing of convertible senior notes due 2021",
        "date": "09082016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet announces pricing of convertible senior notes due 2021 "
    },
    {
        "content": "* Insulet announces private offering of convertible senior notes",
        "date": "09062016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet announces private offering of convertible senior notes "
    },
    {
        "content": "* Says on September 1 entered into a materials supplier agreement with Flextronics Medical Sales and Marketing",
        "date": "09012016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet enters into a materials supplier agreement with Flextronics Medical Sales and Marketing "
    },
    {
        "content": "* Q2 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S",
        "date": "08032016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet Corp reports Q2 loss per share of $0.08 from cont ops "
    },
    {
        "content": "* Insulet reaffirms second quarter and full year 2016 guidance",
        "date": "05032016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet reaffirms second quarter and full year 2016 guidance "
    },
    {
        "content": "* Q1 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S",
        "date": "04282016",
        "name": "Insulet Corporation",
        "news_type": "topStory",
        "symbol": "PODD",
        "title": "BRIEF-Insulet Q1 loss per share $0.19 from continuing operations "
    },
    {
        "content": "June 10 Insulet Corp said on Wednesday it received a warning letter from the U.S. Food and Drug Administration over some of the company's insulin pumps.",
        "date": "06102015",
        "name": "Insulet Corporation",
        "news_type": "normal",
        "symbol": "PODD",
        "title": "Insulet gets FDA warning letter over some insulin pumps "
    }
]